Arul Mozhi Selvan Subbiah Karuppiah

Title: Arul Mozhi Selvan Subbiah Karuppiah: Innovator in Anticancer Agents

Introduction

Arul Mozhi Selvan Subbiah Karuppiah is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer agents. With a total of two patents to his name, his work is recognized for its potential impact on cancer treatment.

Latest Patents

Karuppiah's latest patents include innovative compounds that serve as inhibitors for specific protein kinases. The first patent involves substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives, which are designed to inhibit casein kinase 1 D/E activity. These compounds, along with their pharmaceutically acceptable salts, are aimed at providing new avenues for cancer therapy. The second patent focuses on substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors, which also inhibit protein kinase activity, making them valuable in the fight against cancer.

Career Highlights

Karuppiah is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in the pharmaceutical industry. His work is characterized by a commitment to developing effective treatments for cancer, showcasing his dedication to improving patient outcomes.

Collaborations

Throughout his career, Karuppiah has collaborated with talented individuals such as Upender Velaparthi and Chetan Padmakar Darne. These collaborations have contributed to the innovative research and development of new therapeutic agents.

Conclusion

Arul Mozhi Selvan Subbiah Karuppiah is a distinguished inventor whose work in developing anticancer agents has the potential to make a significant impact in the medical field. His contributions through patents and collaborations highlight his commitment to advancing cancer treatment.